Cargando…
Tumor Necrosis Factor-Alpha Targeting Can Protect against Arthritis with Low Sensitization to Infection
Tumor necrosis factor-alpha (TNF-α) blockade is an effective treatment for rheumatoid arthritis (RA) and other inflammatory diseases, but in patients, it is associated with reduced resistance to the infectious agents Mycobacterium tuberculosis and Listeria monocytogenes, among others. Our goal was t...
Autores principales: | Belmellat, Nadia, Semerano, Luca, Segueni, Noria, Damotte, Diane, Decker, Patrice, Ryffel, Bernhard, Quesniaux, Valérie, Boissier, Marie-Christophe, Assier, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694445/ https://www.ncbi.nlm.nih.gov/pubmed/29184553 http://dx.doi.org/10.3389/fimmu.2017.01533 |
Ejemplares similares
-
Innate type 1 immune response, but not IL-17 cells control tuberculosis infection
por: Segueni, Noria, et al.
Publicado: (2021) -
Active immunization to tumor necrosis factor-α is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis
por: Delavallée, Laure, et al.
Publicado: (2009) -
Limited Contribution of IL-36 versus IL-1 and TNF Pathways in Host Response to Mycobacterial Infection
por: Segueni, Noria, et al.
Publicado: (2015) -
Relative contribution of IL-1α, IL-1β and TNF to the host response to Mycobacterium tuberculosis and attenuated M. bovis BCG
por: Bourigault, Marie-Laure, et al.
Publicado: (2013) -
Innate myeloid cell TNFR1 mediates first line defence against primary Mycobacterium
tuberculosis infection.
por: Segueni, Noria, et al.
Publicado: (2016)